VCIM
NKGNW

Velan Capital Investment Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Velan Capital Investment Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,000
Closed -$5K – 27
2022
Q2 		$5K Hold
20,000
– – 0.01% 23
2022
Q1 		$11K Hold
20,000
– – 0.01% 22
2021
Q4 		$23K Buy
+20,000
New +$20.3K 0.02% 25

Other funds holding NKGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Velan Capital Investment Management's NKGNW Position: Q3 2022 in Review

Velan Capital Investment Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2022, closing a stake of 20,000 shares — an estimated $5K sold.

Velan Capital Investment Management first reported a position in NKGNW in Q4 2021 and held it in 3 quarters. The position peaked at $23K in Q4 2021. 32 funds tracked by Wall St. Rank hold NKGNW as of Q3 2022.

  • Velan Capital Investment Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
  • Velan Capital Investment Management sold 20,000 NKGen Biotech, Inc. Warrants shares in Q3 2022, an estimated $5K.
  • Velan Capital Investment Management first reported a position in NKGen Biotech, Inc. Warrants in Q4 2021 and held it in 3 quarters.
  • Velan Capital Investment Management's NKGen Biotech, Inc. Warrants position peaked at $23K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2022.

Based on Velan Capital Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.